[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Morphine-India Market Status and Trend Report 2013-2023

February 2018 | 142 pages | ID: MD86F04F89FMEN
MIReports Co., Limited

US$ 2,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Morphine-India Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Morphine industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole India and Regional Market Size of Morphine 2013-2017, and development forecast 2018-2023
Main market players of Morphine in India, with company and product introduction, position in the Morphine market
Market status and development trend of Morphine by types and applications
Cost and profit status of Morphine, and marketing status
Market growth drivers and challenges

The report segments the India Morphine market as:

India Morphine Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

North India
Northeast India
East India
South India
West India

India Morphine Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Oral Tablets
Injection
Capsule
Others

India Morphine Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

Anesthesia
Cough Suppressant
Diarrhea suppressant

India Morphine Market: Players Segment Analysis (Company and Product introduction, Morphine Sales Volume, Revenue, Price and Gross Margin):

Mallinckrodt Pharmaceuticals
Alcaliber
Purdue Pharma
Cepia-Sanofi
Macfarlan Smith
SUN PHARMA
Qinghai Pharmaceutical
Taj Pharmaceuticals
Northeast Pharm

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF MORPHINE

1.1 Definition of Morphine in This Report
1.2 Commercial Types of Morphine
  1.2.1 Oral Tablets
  1.2.2 Injection
  1.2.3 Capsule
  1.2.4 Others
1.3 Downstream Application of Morphine
  1.3.1 Anesthesia
  1.3.2 Cough Suppressant
  1.3.3 Diarrhea suppressant
1.4 Development History of Morphine
1.5 Market Status and Trend of Morphine 2013-2023
  1.5.1 India Morphine Market Status and Trend 2013-2023
  1.5.2 Regional Morphine Market Status and Trend 2013-2023

CHAPTER 2 INDIA MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Morphine in India 2013-2017
2.2 Consumption Market of Morphine in India by Regions
  2.2.1 Consumption Volume of Morphine in India by Regions
  2.2.2 Revenue of Morphine in India by Regions
2.3 Market Analysis of Morphine in India by Regions
  2.3.1 Market Analysis of Morphine in North India 2013-2017
  2.3.2 Market Analysis of Morphine in Northeast India 2013-2017
  2.3.3 Market Analysis of Morphine in East India 2013-2017
  2.3.4 Market Analysis of Morphine in South India 2013-2017
  2.3.5 Market Analysis of Morphine in West India 2013-2017
2.4 Market Development Forecast of Morphine in India 2017-2023
  2.4.1 Market Development Forecast of Morphine in India 2017-2023
  2.4.2 Market Development Forecast of Morphine by Regions 2017-2023

CHAPTER 3 INDIA MARKET STATUS AND FORECAST BY TYPES

3.1 Whole India Market Status by Types
  3.1.1 Consumption Volume of Morphine in India by Types
  3.1.2 Revenue of Morphine in India by Types
3.2 India Market Status by Types in Major Countries
  3.2.1 Market Status by Types in North India
  3.2.2 Market Status by Types in Northeast India
  3.2.3 Market Status by Types in East India
  3.2.4 Market Status by Types in South India
  3.2.5 Market Status by Types in West India
3.3 Market Forecast of Morphine in India by Types

CHAPTER 4 INDIA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Morphine in India by Downstream Industry
4.2 Demand Volume of Morphine by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Morphine by Downstream Industry in North India
  4.2.2 Demand Volume of Morphine by Downstream Industry in Northeast India
  4.2.3 Demand Volume of Morphine by Downstream Industry in East India
  4.2.4 Demand Volume of Morphine by Downstream Industry in South India
  4.2.5 Demand Volume of Morphine by Downstream Industry in West India
4.3 Market Forecast of Morphine in India by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF MORPHINE

5.1 India Economy Situation and Trend Overview
5.2 Morphine Downstream Industry Situation and Trend Overview

CHAPTER 6 MORPHINE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN INDIA

6.1 Sales Volume of Morphine in India by Major Players
6.2 Revenue of Morphine in India by Major Players
6.3 Basic Information of Morphine by Major Players
  6.3.1 Headquarters Location and Established Time of Morphine Major Players
  6.3.2 Employees and Revenue Level of Morphine Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 MORPHINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Mallinckrodt Pharmaceuticals
  7.1.1 Company profile
  7.1.2 Representative Morphine Product
  7.1.3 Morphine Sales, Revenue, Price and Gross Margin of Mallinckrodt Pharmaceuticals
7.2 Alcaliber
  7.2.1 Company profile
  7.2.2 Representative Morphine Product
  7.2.3 Morphine Sales, Revenue, Price and Gross Margin of Alcaliber
7.3 Purdue Pharma
  7.3.1 Company profile
  7.3.2 Representative Morphine Product
  7.3.3 Morphine Sales, Revenue, Price and Gross Margin of Purdue Pharma
7.4 Cepia-Sanofi
  7.4.1 Company profile
  7.4.2 Representative Morphine Product
  7.4.3 Morphine Sales, Revenue, Price and Gross Margin of Cepia-Sanofi
7.5 Macfarlan Smith
  7.5.1 Company profile
  7.5.2 Representative Morphine Product
  7.5.3 Morphine Sales, Revenue, Price and Gross Margin of Macfarlan Smith
7.6 SUN PHARMA
  7.6.1 Company profile
  7.6.2 Representative Morphine Product
  7.6.3 Morphine Sales, Revenue, Price and Gross Margin of SUN PHARMA
7.7 Qinghai Pharmaceutical
  7.7.1 Company profile
  7.7.2 Representative Morphine Product
  7.7.3 Morphine Sales, Revenue, Price and Gross Margin of Qinghai Pharmaceutical
7.8 Taj Pharmaceuticals
  7.8.1 Company profile
  7.8.2 Representative Morphine Product
  7.8.3 Morphine Sales, Revenue, Price and Gross Margin of Taj Pharmaceuticals
7.9 Northeast Pharm
  7.9.1 Company profile
  7.9.2 Representative Morphine Product
  7.9.3 Morphine Sales, Revenue, Price and Gross Margin of Northeast Pharm

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF MORPHINE

8.1 Industry Chain of Morphine
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF MORPHINE

9.1 Cost Structure Analysis of Morphine
9.2 Raw Materials Cost Analysis of Morphine
9.3 Labor Cost Analysis of Morphine
9.4 Manufacturing Expenses Analysis of Morphine

CHAPTER 10 MARKETING STATUS ANALYSIS OF MORPHINE

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications